ByramConnect™ for Health Plan Members
Diabetes Digital Solution for Lowering Patient A1C and Provider Costs1,2,3
ByramConnect™, Powered by Welldoc®, provides a 24/7 digital coach that can help your members better self-manage their diabetes, resulting in reductions in A1C, leading to healthier, more productive lives while helping to reduce your plan costs1, 2, 3
CONTACT US
![Phone with Splash Screen](/-/media/byram-connect/healthplansservices.png)
![Green Background Element](/-/media/byram-connect/green-triangle-bg.png)
![Blue Background Element](/-/media/byram-connect/blue-triangle-bg.png)
Byram Connect™ Can Help Lower A1C 1-2 Points and Save $3k - $5.2k Annually on Your Diabetes Members1,2,3
At Byram Healthcare, We Understand the Challenges with Diabetes
- 1 in 4 healthcare dollars are spent on diabetes and its complications, costing more than $327B4
- Medications are only taken as prescribed about 50% of the time5
- Providers lack access to timely, actionable insights to help them best treat their patients
ByramConnect™ Was Developed to Help
- Members – lower their A1C 1-2 points2,3 & gain improved health with a simple, integrated user experience
- Providers – access timely, actionable feedback to better care for their patients
- Health Plan Payers – gain clinical insights, lower A1C, lower costs1,2,3 and improved quality scores
- Employers – take advantage of healthier, more productive employees and lower healthcare costs
Brought to you by
Byram Healthcare,
Rated ”Best Overall Diabetic Supply Company” by Verywell Health for the Past 3 years
2022 | 2021 | 2020
![front facing phone with diabetes management screen](/-/media/byram-connect/front-facing-phone.png)
Features and Benefits
Give Your Members a “Coach in Your Pocket” for Improved Self-Care
Empower your members with the tools and guidance they need to analyze, guide, and improve their daily diabetes self-management.
![24/7 icon](/-/media/byram-connect/247-1.png)
Individualized, 24/7 Real-time Feedback and Actionable Insights from >950,000 messages to guide you every step of the way to manage your unique needs
![brain icon](/-/media/byram-connect/ai-new-1.png)
Artificial Intelligence that monitors, analyzes, and identifies patterns and trends for blood glucose, food, blood pressure, medications, weight, activity, sleep & more
![](/-/media/byram-connect/certified-1.png)
Certified Diabetes Care & Education Specialists available to you for additional support
Hub for collecting data
![front facing phone](/-/media/byram-connect/basics-200x400-2.png)
![front facing phone](/-/media/byram-connect/dinner-200x400-1.png)
![front facing phone](/-/media/byram-connect/discover-200x400-3.png)
Watch How ByramConnect™ Can Help Improve Overall Health & Lower Costs1, 2, 3
To view with Open Captioning Click Here
Digital Diabetes Solution Addresses the Challenges with Diabetes
More than 60+ peer-reviewed randomized clinical trials, studies, whitepapers, posters and publications highlight the ability of this diabetes digital health solution to:
![Checkmark](/-/media/byram-connect/checkmark.png)
Improve Member Health & Productivity
With lower A1C and better diabetes self-management
![Checkmark](/-/media/byram-connect/checkmark.png)
Generate Cost Savings
Estimated cost savings ranging from $3,048 – $5,244 per user annually for A1C >8 resulting from managing glycemic variability1
![Checkmark](/-/media/byram-connect/checkmark.png)
Increase Medication Adherence
Medication reminder is among the most frequently used features by App users
![Checkmark](/-/media/byram-connect/checkmark.png)
Insights for Providers and Care Teams
Engaged users can share their data and insights with physicians and care teams
Cost Analysis
A1C Reduction and Cost Savings3
![reduction chart](/-/media/byram-connect/reduction-chart.png)
*BlueStar Rx/OTC is an FDA-cleared medical device, is indicated for use by patients aged 18 and older who have Type 1 or Type 2 diabetes and their healthcare providers. For full labeling information, visit www.welldoc.com.
Analysis of Costs in Partnership with IBM Watson Health1
Starting and ending A1C values were provided from 3,000+ app users to IBM Watson Health. User data was run through IBM’s MarketScan claims database of more than 80 million individuals to correlate cost savings due to a reduction of:
Cost Savings
$3,048-
$5,244
(Per Person Anually)
![Ambulance 3](/-/media/byram-connect/ambulance.png)
Hospitalizations, ER visits, and HCP office visits
![Medication photo](/-/media/byram-connect/medication.png)
Cost of medical devices, supplies, and medications
![Heart photo](/-/media/byram-connect/heart-with-pulse.png)
Cost of co-morbid conditions (weight, hypertension, etc.)
Annual Savings by Starting A1C Bands
A1C bands
estimated cost savings (per patient annually)
estimated cost savings (per patient, annually)
Studies in Type-2 Diabetes
3-Month randomized-controlled clinical trial
In a prospective, randomized, controlled study, Quinn et al. (Diabetes Technology and Therapeutics, 2008) found that individuals whose A1C levels were greater than or equal to 7.5% within most recent three months and received BlueStar software experienced an average decrease in A1C of 2.03%. Patients in the control group obtained an average A1C reduction of 0.68% (P < 0.02, one-tailed). Of the intervention patients, 84% had medications titrated or changed by their HCP compared to controls (23%, P=0.002).
READ ABSTRACT12-Month randomized-controlled clinical trial
In a prospective, randomized, controlled study, Quinn et al. (Diabetes Care, 2011) found that, individuals with type 2 diabetes whose A1C levels were poorly controlled (>9.0%) or abnormal (7.5-8.9%) at the time of enrollment, and who were randomized to use a mobile phone app to help them manage their diabetes in addition to usual care, improved A1C by an average 1.9%, compared with 0.7% improvement in persons randomized to usual care alone, a difference of 1.2% (P < 0.001) over 12 months.
READ ABSTRACTThe ByramConnect™ app, powered by BlueStar®, is indicated for use by patients aged 18 and older who have Type 1 or Type 2 diabetes and their healthcare providers. The app is not intended to replace the care provided by a licensed healthcare professional. The app should not be used by patients with gestational diabetes or patients using an insulin pump. BlueStar® is a Welldoc®, Inc. patented system.
Research is conducted by Welldoc® utilizing BlueStar®* product data on file in conjunction with Welldoc partners. Byram Connect™ is equivalent to the Welldoc BlueStar product.
*BlueStar Rx/OTC is an FDA-cleared medical device, is indicated for use by patients aged 18 and older who have Type 1 or Type 2 diabetes and their healthcare providers. For full labeling information, visit www.welldoc.com.
1 IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.
2 Tang PY, Duni J, Peeples MM, et al. Complementarity of digital health and peer support: “This Is What’s Coming.” Front Clin Diabetes Health. 2021;2. doi:10.3389/fcdhc.2021.646963
3 Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile Diabetes Intervention for Glycemic Control. Journal of Diabetes Science and Technology. 2014;8(2):362-370. doi:10.1177/1932296813514503
4 Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017 Estimates of Diabetes and Its Burden in the United States Background.; 2020. National Diabetes Statistics Report
5 Mayo Clinic Proceedings Medication Adherence: WHO Cares?